The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation

MA Virmani, M Cirulli - International journal of molecular sciences, 2022 - mdpi.com
Mitochondria control cellular fate by various mechanisms and are key drivers of cellular
metabolism. Although the main function of mitochondria is energy production, they are also …

Mitochondrial diseases: a diagnostic revolution

KR Schon, T Ratnaike, J van den Ameele, R Horvath… - Trends in Genetics, 2020 - cell.com
Mitochondrial disorders have emerged as a common cause of inherited disease, but are
traditionally viewed as being difficult to diagnose clinically, and even more difficult to …

Valproic acid induced liver injury: An insight into molecular toxicological mechanism

D Ezhilarasan, U Mani - Environmental Toxicology and Pharmacology, 2022 - Elsevier
Valproic acid (VPA) is an anti-seizure drug that causes idiosyncratic liver injury. 2-propyl-4-
pentenoic acid (Δ 4 VPA), a metabolite of VPA, has been implicated in VPA-induced …

Therapeutic and toxic effects of valproic acid metabolites

NA Shnayder, VV Grechkina, AK Khasanova… - Metabolites, 2023 - mdpi.com
Valproic acid (VPA) and its salts are psychotropic drugs that are widely used in neurological
diseases (epilepsy, neuropathic pain, migraine, etc.) and psychiatric disorders …

Endoplasmic reticulum stress and mitochondrial stress in drug-induced liver injury

S Pu, Y Pan, Q Zhang, T You, T Yue, Y Zhang, M Wang - Molecules, 2023 - mdpi.com
Drug-induced liver injury (DILI) is a widespread and harmful disease closely linked to
mitochondrial and endoplasmic reticulum stress (ERS). Globally, severe drug-induced …

Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro

L Ma, Y Wang, X Chen, L Zhao, Y Guo - Toxicology, 2020 - Elsevier
Valproic acid (VPA) is a widely prescribed antiepileptic drug, which may cause steatosis in
the liver. Oxidative stress is associated with the progression of VPA-induced hepatic …

Valproic acid-induced liver injury: A case-control study from a prospective pharmacovigilance program in a tertiary hospital

ES Meseguer, MU Elizalde, AM Borobia… - Journal of Clinical …, 2021 - mdpi.com
Introduction: Valproic acid (VPA) is an antiepileptic drug extensively used for treating partial
and generalised seizures, acute mania and as prophylaxis for bipolar disorder. Drug …

Detailed molecular mechanisms involved in drug-induced non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: An update

LG Di Pasqua, M Cagna, C Berardo, M Vairetti… - Biomedicines, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
some of the biggest public health challenges due to their spread and increasing incidence …

Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment

X Zhang, Q Geng, L Lin, L Zhang, C Shi, B Liu, L Yan… - Toxicology, 2024 - Elsevier
Abstract Drug-Induced Liver Injury (DILI) and herb Induced Liver Injury (HILI) continues to
pose a substantial challenge in both clinical practice and drug development, representing a …

Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activity

M Kühne, H Lindemann, C Grune, D Schröder… - Journal of Controlled …, 2021 - Elsevier
The development of bio-based nanoparticles (NPs) as drug containers is of increasing
interest to circumvent several obstacles in drug therapy such as rapid drug metabolization …